Evotec Invests €15m In AI-driven Exscientia

 
• By Lubna Ahmed

Evotec has deepened its relationship with artificial intelligence company Exscientia by investing €15m in the UK-based company; the CRO wants to build on the pair's existing collaboration in immuno-oncology and use its stake to diversify the AI firm's portfolio.

3D illustration. Artificial neuron in concept of artificial intelligence. Wall-shaped binary codes make transmission lines of pulses and/or information in an analogy to a microchip.
Extending innovation from biology to chemistry

More from AI

More from Digital Technologies